Heidelberg Pharma AG Release according to Article 41 of the WpHG the German Securities Trading Act with the objective of Europewide distribution

Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Heidelberg Pharma AG / Total Voting Rights Announcement 28.02.2019 / 13:56 Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Publication of total number of voting rights 1. Details of issuer Heidelberg Pharma AG Schriesheimer Str. 101 68526 Ladenburg Germany 2. Type of capital measure Type of capital measure Date of status / date of effect X Conditional capital increase (Sec. 41 para. 2 WpHG) 28.02.2019 Other capital measure (Sec. 41 para. 1 WpHG) 3. New total number of voting rights: 28.143.860 28.02.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	Heidelberg Pharma AG
Schriesheimer Str. 101
68526 Ladenburg
Germany
Internet:	www.heidelberg-pharma.com

End of News	DGAP News Service

More From BioPortfolio on "Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution"